Modification of alpha-2 presynaptic receptor activity and catecholamine release following chronic MAO inhibition

  • J. P. M. Finberg
  • G. Ari
  • G. Lavian
  • D. Hovevey-Sion
Conference paper
Part of the Journal of Neural Transmission book series (NEURAL SUPPL, volume 32)


Neuronal release of noradrenaline from the isolated rat vas deferens has been studied following long-term MAO inhibition. Fractional release of 3H-noradrenaline in response to electrical field stimulation was reduced following chronic clorgyline treatment, but yohimbine equalised the fractional release to that of control animals. Endogenous release of noradrenaline was increased 1.8 fold in yohimbine-treated tissues from rats treated chronically with clorgyline, while tissue noradrenaline content increased 2.3 fold.

Electrophysiological activity measured from the renal nerve of anaesthetised rats decreased following acute treatment with clorgyline. This effect was absent following pretreatment with yohimbine.

From isolated tissue studies, there was no conclusive evidence for downregulation of α2-presynaptic receptors by long-term MAO inhibition. Acute MAO inhibition with clorgyline produces distinct physiological effects in the CNS, but not in peripheral sympathetic nerves.


Monoamine Oxidase Inhibitor Electrical Field Stimulation Renal Nerve Fractional Release Presynaptic Receptor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Blier P, De Montigny C (1985) Serotonergic but not noradrenergic neurons in rat CNS adapt to long-term treatment with monoamine oxidase inhibitors. Neuroscience 16:949–955.PubMedCrossRefGoogle Scholar
  2. Buu NT (1989) Modification of vesicular dopamine and norepinephrine by monoamine oxidase inhibitors. Biochem Pharmacol 38:1685–1692.PubMedCrossRefGoogle Scholar
  3. Campbell IC, Gallager DW, Hamburg MA, Tallman JF, Murphy DL (1985) Electrophysiological and receptor studies in rat brain: effects of clorgyline. Eur J Pharmacol 111:355–365.PubMedCrossRefGoogle Scholar
  4. Clarke DE, Sampath SS (1973) Studies on the functional role of intraneuronal monoamine oxidase. J Pharmacol Exp Ther 187:539–549.PubMedGoogle Scholar
  5. Cohen RM, Campbell IC, Dauphin M, Tallman JF, Murphy DL (1982) Changes in α-and β-receptor densities in rat brain as a result of treatment with monoamine oxidase inhibiting antidepressants. Neuropharmacology 21:293–298.PubMedCrossRefGoogle Scholar
  6. Eisenhofer G, Ropchak TG, Stull RW, Goldstein DS, Keiser HR, Kopin IJ (1987) Dihydroxyphenylglycol and intraneuronal metabolism of endogenous and exogenous norepinephrine in the rat vas deferens. J Pharmacol Exp Ther 241:547–553.PubMedGoogle Scholar
  7. Finberg JPM (1987) Antidepressant drugs and down-regulation of presynaptic receptors. Biochem Pharmacol 36:3557–3562.PubMedCrossRefGoogle Scholar
  8. Finberg JPM, Kopin IJ (1986) Chronic clorgyline treatment enhances release of norepinephrine following sympathetic stimulation in the rat. Naunyn-Schmiedebergs Arch Pharmacol 332:236–242.PubMedCrossRefGoogle Scholar
  9. Finberg JPM, Kopin IJ (1987) Chronic clonidine treatment produces desensitisation of post-but not presynaptic α2-adrenoceptors. Eur J Pharmacol 138:95–100.PubMedCrossRefGoogle Scholar
  10. Finberg JPM, Tal A (1985) Reduced peripheral presynaptic adrenoceptor sensitivity following chronic antidepressant treatment in rats. Br J Pharmacol 84:609–617.PubMedGoogle Scholar
  11. Gomez J, Fillenz M (1982) The effect of tranylcypromine on noradrenergic nerve terminals in different brain regions. Neurochem Int 4:135–141.PubMedCrossRefGoogle Scholar
  12. Goncalves J, Carvalho F, Guimares S (1989) Uptake inhibitors do not change the effect of imidazoline α2-adrenoceptor agonists on transmitter release evoked by single pulse stimulation in mouse vas deferens. Naunyn-Schmiedebergs Arch Pharmacol 339:288–292.PubMedGoogle Scholar
  13. Hovevey-Sion D, Finberg JPM (1987) Chronic inhibition of monoamine oxidase reduces noradrenaline release in rat vas deferens and anococcygeus muscle. Naunyn-Schmiedebergs Arch Pharmacol 336:70–76.PubMedGoogle Scholar
  14. Jarrott B (1971) Occurrence and properties of monoamine oxidase in adrenergic neurons. J Neurochem 18:7–16.PubMedCrossRefGoogle Scholar
  15. Lerner P, Major LF, Murphy DL, Upper S, Lake CR, Lovenberg W (1979) Dopamine-β-hydroxylase and norepinephrine in human cerebrospinal fluid: effects of monoamine oxidase inhibitors. Neuropharmacology 18:423–426.PubMedCrossRefGoogle Scholar
  16. Lerner P, Major LF, Dendel PS, Campbell IC, Murphy DL (1980) Central and peripheral dopamine beta hydroxylase: responses to long term treatment with monoamine oxidase inhibitors. Neuropharmacology 19:877–881.PubMedCrossRefGoogle Scholar
  17. Linnoila M, Karoun F, Potter WZ (1982) Effect of low dose clorgyline on 24-hour binary monoamine excretion in patients with rapidly cycling bipolar affective disorder. Arch Gen Psychiatry 39:513–516.PubMedCrossRefGoogle Scholar
  18. Ross RJ, Scheinin M, Lesieur P, Rudorfer MV, Hauger RL, Siever LJ, Linnoila M, Potter WZ (1985) The effect of clorgyline on noradrenergic function. Psychopharmacology 85:227–230.PubMedCrossRefGoogle Scholar
  19. Siever LJ, Uhde TW, Murphy DL (1982) Possible subsensitization of alpha2-adrenergic receptors by chronic monoamine oxidase inhibitor treatment in psychiatric patients. Psychiatry Res 6:293–302.PubMedCrossRefGoogle Scholar
  20. Stefano FJE, Trendelenburg U (1984) Saturation of monoamine oxidase by in-traneuronal noradrenaline accumulation. Naunyn Schmiedebergs Arch Pharmacol 328:135–141.PubMedCrossRefGoogle Scholar
  21. Sugrue MF (1981) Effect of chronic antidepressant administration on rat frontal cortex α2 and β adrenoceptor binding. Br J Pharmacol 74:760P–761P.Google Scholar
  22. U’Prichard DC, Reisine TD, Mason ST, Fibiger HC, Yamamura HI (1980) Modulation of rat brain α-and β-adrenergic receptor populations by lesion of the dorsal noradrenergic bundle. Brain Res 187:143–154.PubMedCrossRefGoogle Scholar
  23. Youdim MBH, Finberg JPM (1983) Monoamine oxidase inhibitor antidepressants. In: Psychopharmacology, vol 1. Excerpta Medica, Amsterdam, p 38.Google Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • J. P. M. Finberg
    • 1
  • G. Ari
    • 1
  • G. Lavian
    • 1
  • D. Hovevey-Sion
    • 1
  1. 1.Rappaport Family Institute for Research in the Medical Sciences and Faculty of MedicineTechnionHaifaIsrael

Personalised recommendations